Zymeworks Inc. News from TheStreet Pro
This Biotech Name Looks Ready for a Breakout in 2025
Several biotech and biopharma stocks that should prosper in the coming year, particularly one with a leading hepatitis B vaccine.
FDA Approval Has This Mid-Cap Biopharma Stock Playing Our Song
The prospects for this profitable, low-beta, name brightened this past week. here;s how to play it.
Jazz Pharmaceuticals Has the Kind of Rhythm You Want to Keep Playing
This mid-cap biotech is ideal for a 'rinse, wash and repeat' trade.
Should Investors Get Jazzed Up About This Small-Cap Biotech?
Zymeworks has been hot since last October. But there's a specific reason for that.
Take a Look Under the Microscope at These Two Biopharma Stocks
I've noticed that biotech has been one area of strength lately.
Why Are Insiders Buying These 2 Stocks?
An oncology and a oil & gas concern, new names on my list, have my attention.
Wall Street Ends Friday With Small Gains: LIVE MARKETS BLOG
All three indices tacked on modest increases.
Breaking News
Many billionaire tech CEOs will be at Donald Trump’s inauguration (but not all)
One Silicon Valley leader will not be joining his Magnificent 7 CEO peers
Toyota has a dirty political secret that hurts its 'green' image
Toyota's 'squeaky clean' image as the Prius brand is a bit foggy.
Fidelity analyst unveils market forecast for 2025
The veteran analyst explains what could happen to markets in 2025.
Significant changes coming for Social Security payments in 2025
Here’s what retired Americans can expect for the year ahead.